Pfizer's role in the response to COVID-19 has brought it back to the forefront of the pharmaceutical industry and helped it rise 34 spots on the Fortune 500 list this year. Johnson & Johnson: In the latest Fortune rankings, life science giant J&J ranked 37th on the list of 500 companies. Zoetis: The last pharmaceutical company on the Fortune 500 list is Zoetis, an animal health company, based in New Jersey. Bristol-Myers Squibb: At 138 on the Fortune 500 list, BMS rose seven spots from the previous year.
However, Pfizer's profit percentage fell by 47%, Fortune said, which explains the drop in the ranking. Twenty pharmaceutical companies are included in the annual list that Fortune compiles to rank the 500 highest-earning American companies.